Vasocure is a novel therapeutics company developing peptide medicines for vascular disease, centered on Pedifin, its patented F11R blocker for neointimal disease and atherosclerosis. Founded by nephrologists and scientists involved in discovering the human F11 receptor, the company draws on more than two decades of research into vascular access failure in dialysis patients. Its 62-candidate pipeline spans nephrology, cardiology, and oncology, with Pedifin in preclinical and first-in-human studies.
Access for LifeFounded by Yale-trained vascular surgeon Dr. Roger Mason, Access for Life is developing a patented, sensor-equipped implantable device for vascular access during hemodialysis. The venture-backed medical-device start-up combines vascular and renal clinical expertise with engineering and business leadership, and its technology is currently undergoing in-vivo trials. Its development history includes a 2019 KidneyX Redesign Dialysis Phase 1 win and a 2022 short in-vivo trial at Mount Sinai.FLEETWOOD, NY
Cagent VascularCagent Vascular develops endovascular medical devices for peripheral artery disease, centered on its Serranator balloon catheters and Serration Remodeling Therapy. Co-founded by vascular surgeon Peter Schneider and inventor Robert Giasolli, the Wayne, Pennsylvania company uses focused point force rather than conventional circumferential stretching to open arteries at low pressure. Its platform includes a purpose-built catheter for difficult pedal and critical limb-threatening ischemia cases, alongside technologies still in development.WAYNE, PA
WaveClear VascularWaveClear Vascular is developing a proprietary ultrasonic catheter platform for removing vascular blood clots and calcified occlusions. Its approach combines more than one million controlled micro-cavitations per minute with acoustic micro-streaming and catheter motion, aiming to clear vessels while preserving vessel integrity and allowing targeted drug infusion. Founded by chief biophysicist Jeffrey Vaitekunas, whose career includes more than 25 patents and work on Johnson & Johnson’s UltraCision device, the company is led by a team with deep medical-device and vascular-care experience.
Laminate Medical Technologies LtdFounded in 2012 by engineer Tammy Gilon and Dr. Eyal Orion, Laminate Medical Technologies develops medical devices aimed at making arteriovenous fistulas more usable for people receiving hemodialysis. Its flagship VasQ extravascular support device reinforces the fistula’s connection during maturation and is sold across the United States, Europe, Africa, Singapore and the United Kingdom. The company’s team spans Israel, Europe and the United States, with VasQ supported by CE marking and FDA clinical development.NEW YORK, NY